Business Context and Reporting Period
This Form 8-K was filed by Anthem, Inc. (now Elevance Health, Inc.) on June 4, 2021. The filing serves as a Regulation FD disclosure regarding upcoming investor communications and reaffirmation of full-year financial guidance.
Key Financial Metrics
The filing does not report specific revenue, profit, cash flow, margin, debt, or liquidity figures for a completed period. It focuses exclusively on forward-looking per-share earnings guidance for the full year 2021.
Material Changes and Guidance
Company officers intend to reaffirm the following full-year 2021 net income guidance during upcoming investor meetings:
- Reported Net Income: Greater than $24.05 per share.
- Unfavorable Items: Approximately $1.05 per share of net unfavorable items is included in the reported figure.
- Adjusted Net Income: Greater than $25.10 per share (excluding the aforementioned unfavorable items).
This guidance excludes any adjustment items beyond those reported in the Company's first quarter 2021 earnings release.
Risks and Contingencies
The filing includes a comprehensive list of forward-looking statement risks, including but not limited to:
- Impact of public health epidemics and pandemics, specifically COVID-19.
- Trends in healthcare costs, utilization rates, and premium rate adequacy.
- Regulatory changes affecting the Affordable Care Act (ACA) and Medicare/Medicaid programs.
- Pharmacy Benefit Management (PBM) compliance and contractual risks.
- Legal challenges, litigation costs, and government investigations.
- Financial strength rating downgrades and indebtedness levels.
- Information system modernization and cybersecurity risks.
Investor Verification Checklist
- Verify the specific nature and magnitude of the $1.05 per share in "net unfavorable items" referenced in the Q1 2021 earnings release.
- Monitor upcoming investor presentations to confirm if the $24.05 and $25.10 per share guidance remains unchanged.
- Review the Q1 2021 earnings release for details on the adjustment items excluded from the adjusted net income figure.
- Assess the impact of ongoing regulatory changes to the ACA and Medicaid/Medicare programs on future premium rates.